Evaluating the effects of overdose prevention centers on substance use and mental health in New York City
Official title: CE23-002 - Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City
Funded at New York University School of Medicine · NIH-10917006 · Data updated 2026-11-12
This study is looking at how overdose prevention centers can support people who use different drugs and might also be dealing with mental health challenges, to see if these safe spaces can help lower overdose risks and improve their overall well-being.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2023 |
| Project end | September 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $149,998 |
| NIH project number | 5K01CE003586-02 |
| Project ID | NIH-10917006 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use multiple substances and may also be experiencing mental health challenges.
✕Less likely to help
Patients who do not use multiple substances or do not have any behavioral health issues may not benefit from this research.
What this research studies
This research investigates how overdose prevention centers (OPCs) can help individuals who use multiple substances and may also have mental health issues. By providing a safe space for people to consume drugs under supervision, the study aims to determine if these centers can reduce the risk of overdose and improve overall health outcomes. The research will analyze data from OPCs in New York City, focusing on their impact on overdose rates and the mental health of users. The findings could inform public health strategies and interventions for managing polysubstance use.
Why it matters
Potential benefit: If successful, this research could lead to improved safety and health outcomes for individuals struggling with polysubstance use and mental health disorders.
How similar studies have gone: Previous research in other countries has shown that overdose prevention centers can reduce overdose risks, suggesting potential success for this approach in the U.S.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Allen, Bennett — New York University School of Medicine
- Study coordinator: Allen, Bennett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.